Sonendo, Inc. (NYSE:SONX) Q3 2023 Earnings Call Transcript

Michael Watts: So Justin, I’ll take the first half. It’s Mike. So for 2024 guidance, we’re not at this time, ready to give specifics on 2024. We have, of course, put the pricing tiers in place in February. And for the most part, people understand our principles behind that. Customers understand the value that we bring to the procedure and overall to their practice and how we can help them achieve positive results through — GentleWave, both clinically and financially. So with that in mind, we think price is a lever that is appropriate for us to continue to evaluate. I think the second half of your question just talked about certain customers and Bjarne mentioned it a moment ago, just about the customers at the highest tier. And we’ll continue to work with them.

We think that there’s practices out there that are utilizing GentleWave as an adjunct to root canal therapy, and we think we can help them incorporate more fully into their practice and realize the full benefits of GentleWave, not only for the patient having lower pain, but also the practitioner having more efficiencies and better clinical workflow. So with those two things in mind, it just goes back to the value that we bring overall with the GentleWave to the root canal therapy.

Operator: [Operator Instructions] It appears we have no further questions. I’ll now hand back to Bjarne for any closing comments.

Bjarne Bergheim: Thank you, operator. To conclude today’s call, we would just like to reiterate our commitment to Sonendo’s fundamentals and the opportunity ahead of us to drive market adoption and revolutionize dental care. We are incredibly excited about the future of the Company. We look forward to providing additional details at future events. We appreciate everyone’s time today, and thank you for your interest in Sonendo. Have a great evening.

Operator: Thank you. This now concludes today’s call. Thank you all for joining. You may now disconnect your lines.